Veeva Systems Inc. (VEEV) is a highly innovative, multinational cloud-computing company that specializes in cloud-based software for the global life sciences industry. Headquartered in Pleasanton, California, USA, Veeva is a leader in cloud-based solutions in the pharmaceutical and life sciences space, contributing substantially to making the industry more efficient, effective, and accountable.
Founded in 2007 by Peter Gassner and Matt Wallach, Veeva Systems quickly emerged as a significant player in the SaaS (Software as a Service) market. The company carved a niche for itself by proving cloud-based solutions for a traditionally complex and heavily regulated industry. It has established partnerships with major pharmaceutical companies, medical companies, and research institutions worldwide, devoting its resources to support and innovate clinical, regulatory, and quality processes in the life sciences domain.
Veeva Systems' most popular products include Veeva Vault, Veeva CRM, and Veeva Network. Veeva Vault is a content management platform and suite of applications specifically designed for life sciences businesses, providing the capability to manage both content and data in a unified platform. Veeva CRM is an advanced and fully integrated customer relationship management application designed to help life sciences companies engage their customers across multiple channels efficiently. Veeva Network provides accurate customer data to enhance companies' customer interactions.
Thanks to its consistent performance and innovative products, Veeva Systems has consistently witnessed substantial growth since its inception. The company went public in 2013, and its stock has performed well in the stock market, which is a strong indicator of investors' confidence in the company's growth prospects and the improvement in the adoption rate of cloud services among life sciences firms.
Moreover, Veeva Systems leverages a robust corporate culture to drive its growth. The company has a strong work ethic and considers its employees its most significant assets. It believes in creating a work-life balance for its employees and provides them with generous benefits packages.
In conclusion, Veeva Systems Inc. stands at the forefront of the digital transformation wave in the life sciences industry. The company's focus on cloud solutions for regulated industries, coupled with its commitment to innovation and employee satisfaction, equates to a significant market impact and sustains its position as a leader in the field.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
This article provides an overview of Veeva Systems (VEEV) stock, including its current price, market capitalization, P/E ratio, and profitability. It also details the company's business model as a Public Benefit Corporation providing cloud-based software for the life sciences industry and highlights analyst coverage and price predictions for the stock.
Veeva Systems (NYSE: VEEV) shares surged 9% after the company reported a strong fiscal second-quarter performance, exceeding revenue and earnings estimates. The life sciences cloud software provider also raised its full-year outlook, driven by robust performance in its Vault CRM and growing traction for its new AI platform, Veeva Falcon. Investor enthusiasm for enterprise AI adoption contributed to the broader software-sector surge, impacting peers like Salesforce and CrowdStrike positively.
Veeva Systems, a leading cloud-based software provider for the life sciences industry, is bolstering its long-term potential through significant investments in AI capabilities. These investments, highlighted by recent launches and acquisitions, are driving momentum and strengthening Veeva's product portfolio. The company's vertical focus allows it to tailor solutions specifically for its customers, making its offerings highly attractive in the market.
_07_03_2026_03_50_21_133108.jpg)
Veeva Systems Director Priscilla Hung sold 750 shares of the company's Class A Common Stock on September 9, 2026, at a price of $261.0405 per share. This transaction was disclosed in an SEC Form 4 filing dated September 11, 2026. Following the sale, Hung directly holds 3,242 shares of Veeva Systems Class A Common Stock.
Veeva Systems Director Gordon Ritter reported changes in his beneficial ownership of Class A Common Stock through a Form 4 filing on September 3, 2026, effective September 1, 2026. These changes included an in-kind distribution of 250,000 shares from Emergence Capital Partners II, L.P., an increase of 15,585 shares for The Ritter-Metzler Revocable Trust, and the vesting of 541 Restricted Stock Units (RSUs) which added to his direct holdings. The transactions reflect adjustments in his indirect and direct holdings in Veeva Systems.